Read + Share
van Brummelen EMJ, Huijberts S, van Herpen C, Desar I, et al. Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated
Colorectal, Non-Small Cell Lung, and Pancreatic Cancer. Oncologist 2021;26:290-e545.
PMID: 33296125
|
 |
|
van Brummelen EMJ, Huijberts S, van Herpen C, Desar I, et al. Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated
Colorectal, Non-Small Cell Lung, and Pancreatic Cancer. Oncologist 2021;26:290-e545.
PMID: 33296125
|
|
|
|